Mitigating the Cost Burden of PAH: Evaluating the Value of Timely Treatment with Effective Therapy

Mitigating the Cost Burden of PAH: Evaluating the Value of Timely Treatment with Effective Therapy is organized by Healthcare Made Practical (HMP) Communications LLC and will be held from Mar 19, 2019 - Mar 19, 2020.

Intended Learners:
This activity is designed for Pharmacy directors, medical directors, and other decision makers working in managed care organizations such as private payers, pharmacy benefit managers, Medicare/Medicaid, VA/DOD, large employers, hospitals, ACOs, long-term care, and other segments.

Accreditation:
1.00 CME
1.00 CNE
1.00 CPE
1.00 Participation

Learning Objectives:
After participating in this activity, participants should be better able to:
• Quantify the clinical and economic burdens associated with the delayed diagnosis, suboptimal treatment, and consequent hospitalization of patients with PAH
• Evaluate clinical data regarding the PAH-specific therapies as well as their mechanism of action, efficacy, safety, and implications on mitigating healthcare utilization and costs
• Develop diagnostic, treatment, and follow-up protocols for PAH that reflect guideline recommendations and current clinical evidence and support individualized PAH care
• Inform formulary placement and benefit design decisions with the latest cost data, treatment guidelines, and optimal PAH management strategies

Additional details will be posted as soon as they are available.